| Literature DB >> 32874549 |
Nurul Ashifah Shafie1, Nur Atiqah Suhaili1, Hussein Taha1, Norhayati Ahmad1.
Abstract
Background : Vitex pinnata is a popular ethnomedicinal plant but scientific studies to validate its pharmacological properties are lacking for this plant. This study aims to determine the antioxidant, antimicrobial and wound healing properties of the methanolic extract of the leaves and the hexane, chloroform and ethyl acetate fractions.Entities:
Keywords: Vitex pinnata; antimicrobial; antioxidant; wound excision; wound healing
Mesh:
Substances:
Year: 2020 PMID: 32874549 PMCID: PMC7445684 DOI: 10.12688/f1000research.21310.2
Source DB: PubMed Journal: F1000Res ISSN: 2046-1402
Figure 1. A) Anaesthetized rat with the scale placed near the wound site, labelled with name, post-wounding day and scale bar of 10 mm for measurement analysis. B) Calibration of Image J with known distance in image. C) The outline of the wound is drawn to measure wound area.
Radical scavenging activities (RSA) and quercetin equivalent (QE) concentrations of V. pinnata extracts.
| Extract | RSA (%) | QE
|
|---|---|---|
| Ethyl acetate | 93.6 ± 0.2 | 33.1 ± 0.1 |
| Methanol | 87.8 ± 0.5 | 31 ± 0.2 |
| Chloroform | 58.5 ± 1.5 | 20.3 ± 0.6 |
| Hexane | 15.1 ± 1.4 | 4.5 ± 0.5 |
The values are shown as average ± standard deviation of three replicates.
Zone of inhibition (mm) of V. pinnata extracts.
| Zone of inhibition (mm) | ||||
|---|---|---|---|---|
| Bacteria | Methanol | Hexane | Chloroform | Ethyl
|
|
| 0.0 ± 0.0 | 0.0 ± 0.0 | 8.4 ± 0.1 | 10.2 ± 0.3 |
|
| 0.0 ± 0.0 | 8.2 ± 1.2 | 9.3 ± 0.1 | 9.3 ± 0.5 |
|
| 0.0 ± 0.0 | 8.0 ± 0.4 | 10.3 ± 0.1 | 11.6 ± 0.2 |
|
| 0.0 ± 0.0 | 0.0 ± 0.0 | 0.0 ± 0.0 | 6.2 ± 0.5 |
The values are shown as average ± standard deviation of at least three replicates. Negative control did not show any inhibition zone as expected whereas positive control (streptomycin sulphate) showed inhibition zones ranging from ~20 to 30 mm.
Figure 2. Macroscopic observation of wound healing progress in control and extract-treated groups at given post-wounding time points.
Figure 3. Average percentages of wound contraction of the experimental groups at post-wounding days 7, 14 and 21 (n= 3).
** denote significant changes of wound contraction at day 14 in comparison to control group, **p < 0.01.
Percentage wound contraction for animals receiving low and high dose extracts vs controls.
| Groups | Wound contraction (%) | |||
|---|---|---|---|---|
| Day 3 | Day 7 | Day 14 | Day 21 | |
|
| 2.4 ± 10.1 | 58.8 ± 6.4 | 95.0 ± 0.3 | 99.9 ± 0.1 |
|
| -14.4 ± 19.1 | 37.1 ± 13.4 | 96.6 ± 1.6 | 100 ± 0.0 |
|
| -4.2 ± 8.5 | 47.1 ± 4.1 | 98.7 ± 0.6** | 100 ± 0.0 |
Values are mean ± SEM; **p < 0.01 compared to control animals on similar treatment days. The starting experiment had n=6 animals per group. One animal was sacrificed for histological analysis at day 3, day 7 and day 14. There was n=3 animals remaining at day 21 which is the final day of the experiment.
Figure 4. Histopathological characteristics of wound granulation tissue on post-wounding days 7, 14 and 21 stained with hematoxylin.
Day 3 control and treated rats: presence of inflammatory cells is evident. Collagen deposition observed in the high dose treated animals at day 14. BV: blood vessels; F: fibroblasts; IC: inflammatory cells (x400).